TrialFind
Saved trials
Back to results
Completed
Phase 3
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
NCT02136914
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Birmingham, Alabama, United States
+45 additional locations
View on ClinicalTrials.gov
Official details
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) — TrialFind